TriathlonRSA: Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Standard vs. Short Keel

Sponsor
Region Skane (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02525614
Collaborator
(none)
59
2
180

Study Details

Study Description

Brief Summary

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

Condition or Disease Intervention/Treatment Phase
  • Device: Triathlon Standard Keel
  • Device: Triathlon Short Keel
N/A

Detailed Description

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

The evaluation is carried out by a prospective randomised RSA-study with Triathlon Standard vs. Short Keel.

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Standard vs. Short Keel
Actual Study Start Date :
May 1, 2009
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Triathlon Standard Keel

Triathlon Cruciate Retaining knee (CR) with a tibial keel of standard length randomised against Triathlon Cruciate Retaining knee (CR) with a tibial part with a short keel, both system will be used with cemented fixation. The short tibial keel is thought to facilitate the surgery due to easier access and better positioning possibilities. This study is aimed to evaluate if the short tibial keel will have equal fixation and migration properties as the standard keel.

Device: Triathlon Standard Keel
Implantation of Knee Prosthesis

Active Comparator: Triathlon Short Keel

Triathlon Cruciate Retaining knee (CR) with a tibial keel of standard length randomised against Triathlon Cruciate Retaining knee (CR) with a tibial part with a short keel, both system will be used with cemented fixation. The short tibial keel is thought to facilitate the surgery due to easier access and better positioning possibilities. This study is aimed to evaluate if the short tibial keel will have equal fixation and migration properties as the standard keel.

Device: Triathlon Short Keel
Implantation of Knee Prosthesis

Outcome Measures

Primary Outcome Measures

  1. Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric Analysis (RSA) [10 years follow-up]

    Assessment of fixation and stability of the Triathlon total knee prosthesis by Roentgen Stereophotogrammetric as a predictor of late mechanical loosening.

Secondary Outcome Measures

  1. Investigation of patient outcome with radiographic analysis [3 months, 1, 2, 5, 7 and 10 years]

    Plain radiographs will be obtained for assessment of fixation of the device.

  2. Investigation of clinical performance and patient outcome with KSS (Knee Society Score) [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

    The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, ROM and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

  3. Investigation of clinical performance and patient outcome with KOOS patient questionnaire [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

    KOOS (Knee injury and osteoarthritis outcome score) consists of 5 subscales: Pain, other symptoms, function in daily living, function in sport and recreation and knee related quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms).

  4. Investigation of clinical performance and patient outcome with EQ-5D patient questionnaire [pre-operative, 3 months, 1, 2, 5, 7 and 10 years]

    The EQ-5D (EuroQuol-5 dimension) health questionnaire provides a simple descriptive profile and a single index value for health status.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients suffering exclusively from OA, Stage II-V [Ahlbäck-Traumascore, 1968 391] will be operated.

  2. Patients requiring knee prosthesis, suitable for the use of Duracon and Triathlon knee system

  3. Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographical evaluations and the prescribed rehabilitation.

  4. Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

Exclusion Criteria:
  1. Previous major knee surgery

  2. Other significant disabling problems from the muscular-skeletal system than in the knees

  3. Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI above 35).

  4. Patients with active or suspected infection.

  5. Patients with malignancy - active malignancy.

  6. Patients with severe osteoporosis, Paget's disease, renal osteodystrophy.

  7. Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.

  8. The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period.

  9. Female patients planning a pregnancy during the course of the study.

  10. Patients with systemic or metabolic disorders leading to progressive bone deterioration.

  11. Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.

  12. Patients with other severe concurrent joint involvements, which can affect their outcome.

  13. Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis.

  14. Patients under the protection of law (e.g. guardianship).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Region Skane

Investigators

  • Principal Investigator: Sören Toksvig-Larsen, MD, Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Region Skane
ClinicalTrials.gov Identifier:
NCT02525614
Other Study ID Numbers:
  • K-S-015 Triathlon RSA _4
First Posted:
Aug 17, 2015
Last Update Posted:
Feb 5, 2021
Last Verified:
Feb 1, 2021

Study Results

No Results Posted as of Feb 5, 2021